Intravitreal memantine retinal toxicity in rabbits

Area of Science:

• Ophthalmology
• Neuroscience
• Toxicology

Background:

• Memantine is an NMDA receptor antagonist with potential therapeutic applications.
• Evaluating the safety of intravitreal drug delivery is crucial for ocular treatments.

Purpose of the Study:

• To histologically assess the retinal toxicity of intravitreal memantine in a rabbit model.
• To determine safe dosage ranges for potential ocular applications of memantine.

Main Methods:

• A study involving 16 New Zealand rabbits divided into four groups.
• Intravitreal administration of varying memantine doses (70, 150, 400 ng/ml) or balanced salt solution.
• Histopathological analysis of enucleated eyes at 15 and 30 days post-injection.

Main Results:

• No significant histopathological changes were observed in retinas treated with 70 ng/ml or 150 ng/ml memantine.
• Retinal structural changes, specifically in the photoreceptor layer, were noted in eyes treated with 400 ng/ml memantine.
• Control groups receiving balanced salt solution showed no adverse effects.

Conclusions:

• Intravitreal memantine at concentrations of 70 ng/ml and 150 ng/ml appears safe in rabbit retinas.
• A dose of 400 ng/ml of intravitreal memantine induced retinal toxicity, evidenced by structural changes.
• Further research is warranted to explore the clinical utility and safety profile of memantine in ophthalmology.